Dr Kumar speaks with ecancer at EBMCI 2017 about surgery as the standard of care for lung cancer.

By comparison to developments in treating early lung cancer with stereotactic body radiotherapy, he highlights a lack of compelling trial data, and notes that a direct comparison of outcomes between SBRT and open surgery does not reflect the outcomes possible with laparascopic, or keyhole, surgery.

This topic was part of a debate session at the conference, with the opposing view discussed by Dr Anusheel Munshi here.